HAMELN PHARMA LTD
Get an alert when HAMELN PHARMA LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£2.3m
-14.8% lowest in 6 filed years
Net assets
£14m
+26.3% vs 2024
Employees
32
+10.3% highest in 6 filed years
Profit before tax
£3.8m
-8% vs 2024
Net assets
6-year trend · vs Consumer Discretionary median
Accounts
6-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|---|---|---|
| Turnover | £26,944,212 | £27,885,956 | £25,240,554 | £24,513,442 | £27,407,580 | £28,612,448 | +4.4% | |
| Operating profit | £7,306,861 | £5,797,098 | £6,583,359 | £3,580,000 | £4,174,228 | £3,841,303 | -8% | |
| Profit before tax | £7,302,945 | £5,792,781 | £6,582,100 | £3,573,505 | £4,168,897 | £3,835,591 | -8% | |
| Net profit | £5,912,134 | £4,709,593 | £5,313,600 | £2,730,086 | £2,924,724 | £2,876,693 | -1.6% | |
| Cash | £9,328,345 | £10,639,105 | £9,149,990 | £3,862,306 | £2,724,779 | £2,321,588 | -14.8% | |
| Total assets less current liabilities | £16,426,781 | £17,491,441 | £14,112,882 | £11,630,471 | £10,948,989 | £13,825,682 | +26.3% | |
| Net assets | £16,418,208 | £17,491,441 | £14,109,362 | £11,622,048 | £10,943,072 | £13,819,765 | +26.3% | |
| Equity | £16,418,208 | £17,491,441 | £14,109,362 | £11,622,048 | £10,943,072 | £13,819,765 | +26.3% | |
| Average employees | 26 | 26 | 27 | 29 | 29 | 32 | +10.3% | |
| Wages | £1,561,685 | £1,451,103 | £1,504,756 | £1,965,146 | £2,167,338 | £2,287,648 | +5.6% | |
| Directors' remuneration | £426,029 | £365,003 | £292,885 | £375,667 | £452,276 | £386,650 | -14.5% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|---|---|---|
| Operating margin | 27.1% | 20.8% | 26.1% | 14.6% | 15.2% | 13.4% | |
| Net margin | 21.9% | 16.9% | 21.1% | 11.1% | 10.7% | 10.1% | |
| Return on capital employed | 44.5% | 33.1% | 46.6% | 30.8% | 38.1% | 27.8% | |
| Gearing (liabilities / total assets) | — | — | — | — | 29.6% | 29.7% | |
| Current ratio | — | — | — | 4.51x | 3.37x | 3.36x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 3 times since incorporation
- HAMELN PHARMA LTD 2020-04-01 → present
- HAMELN PHARMACEUTICALS LTD 2004-10-01 → 2020-04-01
- PHOENIX PHARMA LTD. 1998-08-20 → 2004-10-01
- PHOENIX PHARMACEUTICALS LIMITED 1971-12-14 → 1998-08-20
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Bishop Fleming Audit Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Significant events
- “hameln continue to invest in a number of products with a number of new product launches planned for 2026.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 10 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| KUETER, Beate | Director | 2022-04-01 | Nov 1966 | German |
| WATKIN, Stephen Allen | Director | 2022-09-28 | Mar 1967 | British |
Show 10 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CHISHOLM, David Murray | Secretary | 1994-04-21 | 1997-12-31 |
| FORBES, Drummond Romary | Secretary | 1998-01-01 | 2002-05-07 |
| KERSTEIN, Christoph | Secretary | 2002-05-08 | 2003-02-03 |
| SEFTON, Susan Margaret | Secretary | — | 1993-04-21 |
| WATKIN, Stephen Allen | Secretary | 2003-02-03 | 2022-03-31 |
| CHISHOLM, David Murray | Director | — | 1997-12-31 |
| FORBES, Drummond Romary | Director | 1998-01-01 | 2002-05-07 |
| KERSTEIN, Christoph | Director | 1997-01-23 | 2022-09-28 |
| KERSTEIN, Eike | Director | — | 2003-09-30 |
| WATKIN, Stephen Allen | Director | 2003-02-03 | 2022-03-31 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Stephen Allen Watkin | Individual | Significant influence | 2016-04-06 | Ceased 2022-03-31 |
| Mr Christoph Kerstein | Individual | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 121 total filings
Material constitutional events — rename, articles re-file, resolution
- 2022-04-25 MA Memorandum articles
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-07-20 | AA | accounts | Accounts with accounts type full | |
| 2026-05-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-05-18 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2026-05-18 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2025-09-22 | AA | accounts | Accounts with accounts type full | |
| 2025-05-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-09-30 | AA | accounts | Accounts with accounts type full | |
| 2024-05-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-10 | AA | accounts | Accounts with accounts type full | |
| 2023-05-15 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-10-29 | CH01 | officers | Change person director company with change date | |
| 2022-09-29 | AA | accounts | Accounts with accounts type full | |
| 2022-09-28 | AP01 | officers | Appoint person director company with name date | |
| 2022-09-28 | TM01 | officers | Termination director company with name termination date | |
| 2022-05-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-04-25 | MA | incorporation | Memorandum articles | |
| 2022-04-14 | AP01 | officers | Appoint person director company with name date | |
| 2022-04-14 | TM01 | officers | Termination director company with name termination date | |
| 2022-04-14 | TM02 | officers | Termination secretary company with name termination date | |
| 2022-04-14 | PSC07 | persons-with-significant-control | Cessation of a person with significant control |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.